AI Is Nothing Without An AI-Ready Data Strategy
This article highlights the critical role of an AI-ready data strategy in drug discovery, emphasizing that AI is only as effective as the quality of data it processes.
This article highlights the critical role of an AI-ready data strategy in drug discovery, emphasizing that AI is only as effective as the quality of data it processes.
This article highlights the importance of unifying and contextualizing drug discovery data to harness the full potential of advanced analytics.
We recently launched Image Artist™ the fast, efficient image analysis and data management solution for High Content Screening and cellular image data that integrates with Revvity Signals Signals™ VitroVivo for secondary data analysis. High Content Screening is a mainstream technology for drug research. More and more experiments are run on more and modern...
This article highlights the role of data strategies in accelerating the development of new drug modalities
AI and integrated software capabilities are shaping the way scientists conduct research. Read how Josh Bond explains Revvity Signals' vision for the future of scientific research.
Discover how Revvity Signals' dedicated Customer Experience team helps clients build robust, efficient, and cost-effective research operations through expert support, innovative SaaS solutions, and a customer-first approach.
This article discusses the critical importance of centralized data management tools in improving research efficiency within the FAIR (Findable, Accessible, Interoperable, and Reusable) data landscape.
When analyzing data there is often a competition between getting an analysis set up just the way you want versus implementing a consistent method across your data and organization. Often with flexible tools, it is easy to adjust the analysis, but difficult to use it repeatedly at scale. Whereas with scalable tools, once a system is setup, the difficulty of...